Listed

Nutex Health Inc.: Form 10-K for the period ended Dec 31, 2013

Filed with the SEC on Apr 1, 2014 and accepted by EDGAR at Apr 1, 2014, 16:53 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2013-01-01 to 2013-12-31$1.5mus-gaap:SalesRevenueNet
Cost of revenue12 months2013-01-01 to 2013-12-31$496.0kus-gaap:CostOfRevenue
Gross profit12 months2013-01-01 to 2013-12-31$965.2kus-gaap:GrossProfit
Operating income12 months2013-01-01 to 2013-12-31−$727.4kus-gaap:OperatingIncomeLoss
Interest expense12 months2013-01-01 to 2013-12-31−$54.5kus-gaap:InterestExpense
Net income12 months2013-01-01 to 2013-12-31$250.5kus-gaap:NetIncomeLoss
Diluted EPS12 months2013-01-01 to 2013-12-31−$0.01us-gaap:EarningsPerShareBasicAndDiluted
Diluted shares (weighted)12 months2013-01-01 to 2013-12-3125,987,956 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2013-01-01 to 2013-12-31−$183.2kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2013-12-31$26.9kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-12-31$1.1mus-gaap:AssetsCurrent
Total assetsAt period end2013-12-31$1.1mus-gaap:Assets
Current liabilitiesAt period end2013-12-31$515.2kus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2013-12-31$556.2kus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001211524-14-000027. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.